World Smoking Cessation Aids Market

Home >
Consumer Goods and Services >
Personal Care >
World Smoking Cessation Aids Market

Report price : $ 3 950
Publication date : April 2008
Length : 218 pages

This report analyzes the worldwide markets for Smoking Cessation Aids in US$ Million. The major product segments analyzed are Nicotine Gum, Nicotine Patch, Nicotine lozenges & tablets, and Others (Nicotine Inhaler, and Nasal Spray). The report provides separate comprehensive analytics for the US, Canada, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 32 companies including many key and niche players worldwide such as GlaxoSmithKline Plc, Johnson & Johnson Inc., Novartis Consumer Healthcare Inc., Perrigo Company, and Pfizer Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

SMOKING CESSATION AIDS MCP-1591
A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-2
Product Definition and Scope of Study I-3
Smoking Cessation Aids I-3
Definitions I-3
A. Nicotine Gum I-3
B. Nicotine Patch I-4
C. Nicotine Lozenges And Tablets I-4
D. Others I-4
Nicotine Inhaler I-4
Nicotine Nasal Spray I-4

II. EXECUTIVE SUMMARY

1. Industry Outlook II-1
Leading Players II-1
Tobacco Products Industry: An Introduction II-1
Regulations/Taxes II-2
Black Market II-2
Cigarette: The Tobacco King II-3
Cigars: All Rolled Up II-3
Glut of Products Restrain Growth II-3
Major Cigar Tobacco Producing Regions II-3
China Dominates the Cigarettes Sector II-4
Competitive Scenario II-4
Table 1: World Cigarettes Market for 2004 & 2005: Market
Shares Based on Volume Sales of Leading Manufacturers for
Philip Morris, British American Tobacco, Japan Tobacco,
Imperial Tobacco, Gallaher, Reynolds American and Others
(includes corresponding Graph/Chart) II-4

Table 2: World Recent Past, Current & Future Analysis for
Cigarettes by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales
Figures in Billion Units for Years 2000 2006 and 2010
(includes corresponding Graph/Chart) II-5

Table 3: World Recent Past, Current & Future Analysis for
Cigars by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales
Figures in Million Units for Years 2000 2006 and 2010
(includes corresponding Graph/Chart) II-5

Table 4: World Recent Past, Current & Future Analysis for
Cigarettes by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and
Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Billion for Years 2000 2006 and 2010
(includes corresponding Graph/Chart) II-6

Table 5: World Recent Past, Current & Future Analysis for
Cigars by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000, 2006 and 2010
(includes corresponding Graph/Chart) II-6
Why to Quit Smoking II-7
Secondhand Smoke II-7
Why Smoking is Hard to Quit II-7
Methods of Smoking Cessations II-8
Cold Turkey II-8
Drug Therapies II-9
Other Interventions II-9
Benefits of Quitting Smoking II-9

2. World Smoking Statistics II-11

3. Product Overview II-12
Smoking Cessation Aids Defined II-12
Nicotine Gum II-12
Factors to Consider II-12
Effectiveness of Nicotine Gum II-13
Nicotine Patch II-13
Factors to Consider II-14
Nicotine Lozenges & Tablets II-14
Factors to Consider II-15
Other Smoking Cessation Aids II-15
Nicotine Inhaler II-15
Factors to Consider II-15
Nicotine Nasal Spray II-16
Factors to Consider II-16
Non-Nicotine Based Medications II-16

4. Trends and Issues II-17
Inundate Anti-Smoking Vaccines Kindles Underdeveloped
Prescription Market II-17
Strict Regulations Deter Smoking Cessation Aids II-17
Growing Anti Smoking Campaigns II-18
Health Concerns II-18
Corporations Initiate for Smoke Free Work Environment II-18
Television Advertisements - Most Effective Media for Smoking
Cessation II-19
Public Awareness through Internet II-19
Rising Prices of Tobacco - A Key Strategy for Quitting Smoking II-19

5. Product Innovations/Introductions II-20
Acomplia to Enter Smoking Cessation Market II-20
Fertin Phiarma and Perrigo to Launch Nicotine Gum in the US
Market II-20
Nicødrops Unveils New Lozenge for Smoking Cessation II-20
Pharmacia and Takeda to Launch Smoking Cessation Aid in Japan II-20
Glaxo Unveils First Anti-Smoking Medicine in India II-20

6. Recent Industry Activity II-21
Pfizer Japan to Roll Out Champix Anti-Smoking Drug II-21
Inverness Medical Innovations Pockets Bio-Stat Healthcare Group II-21
Novartis New Smoking Cessation Aids Gets FDA’s Approval II-21
Johnson & Johnson Concludes Take Over of Pfizer Consumer
Healthcare II-21
Pfizer Receives FDA Approval for Smoking Cessation Medicine
Chantix™ II-22
Perrigo Obtains FDA Approval to Sell Coated Nicotine Gum II-22
Pfizer Receives Chinese Approval for Clinical Trials on
Smoking Cessation Aid II-22
Pfizer Receives EC Approval for New Varenicline II-22
Formation of Sanofi-Aventis II-22
AXIA Health Management Acquires Smoking Cessation Website II-23
Nicodrops Receives EC Approval for Smoking Cessation Aid II-23
Nabi Unveils Successful Phase II Results for Smoking
Cessation Vaccine II-23
FDA Grants Approval for High Strength Bupropion II-23
Watson Pharmaceuticals Receives Rights to Market Zyban® II-24
Pfizer Merges with Pharmacia II-24
FDA Approves Anti-Smoking Medication for OTC Sales II-24
GSK and Taisho to Develop Anti-Smoking Medication II-24
Johnson & Johnson Acquires Alza II-24

7. Focus on Select Global Players II-25
GlaxoSmithKline Plc (UK) II-25
Johnson & Johnson Inc. (USA) II-25
Novartis Consumer Healthcare Inc. (USA) II-25
Perrigo Company (USA) II-26
Pfizer Inc. (USA) II-26

8. Global Market Perspective II-27
Table 6: World Recent Past, Current & Future Analysis for
Smoking Cessation Aids by Geographic Region - US, Canada,
Europe and Rest of World Independently Analyzed by Annual
Sales in US$ Million for the Years 2000 through 2010
(includes corresponding Graph/Chart) II-27

Table 7: World Long Term Projections for Smoking Cessation
Aids by Geographic Region - US, Canada, Europe and Rest of
World Independently Analyzed by Annual Sales in US$ Million
for the Years 2011 through 2015 (includes corresponding
Graph/Chart) II-28

Table 8: World 10-Year Perspective for Smoking Cessation Aids
by Geographic Region - Percentage Break down of Dollar Sales
for US, Canada, Europe and Rest of the World for the Years
2003, 2008 and 2012 (includes corresponding Graph/Chart) II-29

III. MARKET

1. The United States III-1
A.Market Analysis III-1
Outlook III-1
Cigarette Smoking Decline Stagnates in the US III-1
Smoking Women are at High Risk III-1
Tobacco Companies Spend Big on Advertising III-1
NRT - A Peer into the Past III-1
Popular NRT Brands in the US Market III-2
Key Statistics: III-2
Table 9: Top 4 Nicotine Chewing Gum Brands in the US:
Breakdown of Dollar Sales Through Supermarkets, Drug Stores &
Discount Stores for the Year Ended November 2007 (In US$
000) III-2

Table 10: US Market for Smoking Cessation Products:
Percentage Share Breakdown of Value and Volume Sales by
Product Category - Gum, Patch, Tablets, and Others (incl.
Mouth Spray, Filters) for the Year Ended November 2007
(includes corresponding Graph/Chart) III-3

Table 11: Leading NRT Brands in the US Market by Product
Type in 2005: Sales in US$ Millions for Nicorette, Nicoderm
CQ, Commit and Other Brands & Private Labels (includes
corresponding Graph/Chart) III-3
Product Launches/Developments III-4
Strategic Corporate Developments III-4
Key Players III-6
B.Market Analytics III-9
Table 12: US Recent Past, Current & Future Analysis for
Smoking Cessation Aids by Product Segment - Nicotine Gum,
Nicotine Patches and Lozenges & Tablets Independently
Analyzed by Annual Sales in US$ Million for the Years 2000
through 2010 (includes corresponding Graph/Chart) III-9

Table 13: US Long Term Projections for Smoking Cessation
Aids by Product Segment - Nicotine Gum, Nicotine Patches
and Lozenges & Tablets Independently Analyzed by Annual
Sales in US$ Million for the Years 2011 through 2015
(includes corresponding Graph/Chart) III-9

Table 14: US 10-Year Perspective for Smoking Cessation Aids
by Product Segment - Percentage Breakdown of Dollar Sales
for Nicotine Gum, Nicotine Patches and Lozenges & Tablets
for the Years 2003, 2008 and 2012 (includes corresponding
Graph/Chart) III-10

2. Canada III-11
A.Market Analysis III-11
Outlook III-11
B.Market Analytics III-11
Table 15: Canadian Recent Past, Current & Future Analysis
for Smoking Cessation Aids by Product Segment - Nicotine
Gum, Nicotine Patches and Lozenges & Tablets Independently
Analyzed by Annual Sales in US$ Million for the Years 2000
through 2010 (includes corresponding Graph/Chart) III-11

Table 16: Canadian Long Term Projections for Smoking
Cessation Aids by Product Segment - Nicotine Gum, Nicotine
Patches and Lozenges & Tablets Independently Analyzed by
Annual Sales in US$ Million for the Years 2011 through 2015
(includes corresponding Graph/Chart) III-12

Table 17: Canadian 10-Year Perspective for Smoking Cessation
aids by Product Segment - Percentage Breakdown of Dollar
Sales for Nicotine Gum, Nicotine Patches and Lozenges &
Tablets for the Years 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-12

3. Europe III-13
A.Market Analysis III-13
Outlook III-13
Strategic Corporate Developments III-13
Key Players III-14
B.Market Analytics III-16
Table 18: European Recent Past, Current & Future Analysis
for Smoking Cessation Aids by Geographic Region - France,
Germany, UK, Italy, Spain & Rest of Europe Independently
Analyzed by Annual Sales in US$ Million for the Years 2000
through 2010 (includes corresponding Graph/Chart) III-16

Table 19: European Long Term Projections for Smoking
Cessation Aids by Geographic Region - France, Germany, UK,
Italy, Spain & Rest of Europe Independently Analyzed by
Annual Sales in US$ Million for the Years 2011 through 2015
(includes corresponding Graph/Chart) III-17

Table 20: European Recent Past, Current & Future Analysis
for Smoking Cessation Aids by Product Segment - Nicotine
Gum, Nicotine Patches, Lozenges & Tablets and Others
Independently Analyzed by Annual Sales in US$ Million for
the Years 2000 through 2010 (includes corresponding
Graph/Chart) III-18

Table 21: European Long Term Projections for Smoking
Cessation Aids by Product Segment - Nicotine Gum, Nicotine
Patches, Lozenges & Tablets and Others Independently
Analyzed by Annual Sales in US$ Million for the Years 2011
through 2015 (includes corresponding Graph/Chart) III-18

Table 22: European 10-Year Perspective for Smoking Cessation
Aids by Geographic Region - Percentage Breakdown of Dollar
Sales for France, Germany, UK, Italy, Spain, Russia and Rest
of Europe for the Years 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-19

Table 23: European 10-Year Perspective for Smoking Cessation
Aids by Product Segment - Percentage Breakdown of Dollar
Sales for Nicotine Gum, Nicotine Patches, Lozenges &
Tablets and Others for the Years 2003, 2008 & 2012
(includes corresponding Graph/Chart) III-19

3a. France III-20
A.Market Analysis III-20
Outlook III-20
B.Market Analytics III-20
Table 24: French Recent Past, Current & Future Analysis for
Smoking Cessation Aids by Product Segment - Nicotine Gum,
Nicotine Patches, Lozenges & Tablets and Others
Independently Analyzed by Annual Sales Figures in US$
Million for the Years 2000 through 2010 (includes
corresponding Graph/Chart) III-20

Table 25: French Long Term Projections for Smoking Cessation
Aids by Product Segment - Nicotine Gum, Nicotine Patches,
Lozenges & Tablets, and Others Independently Analyzed by
Annual Sales in US$ Million for the Years 2011 through 2015
(includes corresponding Graph/Chart) III-21

Table 26: French 10-Year Perspective for Smoking Cessation
Aids by Product Segment - Percentage Breakdown of Dollar
Sales for Nicotine Gum, Nicotine Patches, Lozenges &
Tablets, and Others for the Years 2003, 2008 and 2012
(includes corresponding Graph/Chart) III-21

3b. Germany III-22
A.Market Analysis III-22
Outlook III-22
B.Market Analytics III-22
Table 27: German Recent Past, Current & Future Analysis for
Smoking Cessation aids by Product Segment - Nicotine Gum,
Nicotine Patches, Lozenges & Tablets, and Other Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-22

Table 28: German Long Term Projections for Smoking Cessation
Aids by Product Segment - Nicotine Gum, Nicotine Patches,
Lozenges & Tablets, and Others Independently Analyzed by
Annual Sales in US$ Million for the Years 2011 through 2015
(includes corresponding Graph/Chart) III-23

Table 29: German 10-Year Perspective for Smoking Cessation
aids by Product Segment - Percentage Breakdown of Value
Sales for Nicotine Gum, Nicotine Patches, Lozenges &
Tablets, and Other Markets for 2003, 2008 and 2012
(includes corresponding Graph/Chart) III-23

3c. The United Kingdom III-24
A.Market Analysis III-24
Outlook III-24
Table 30: Leading OTC-NRT Brands by Company in the UK in
2005: Percentage Breakdown of Value Sales for Nicorette,
Niquitin CQ, Nicotinell and Others (includes corresponding
Graph/Chart) III-24

Table 31: NRT Advertisement Expenditure by Leading
Companies in the UK in 2005: Percentage Breakdown for
Pfizer, GlaxoSmithKline, Novartis and Others (includes
corresponding Graph/Chart) III-24
B.Market Analytics III-25
Table 32: UK Recent Past, Current & Future Analysis for
Smoking Cessation Aids by Product Segment - Nicotine Gum,
Nicotine Patches, Lozenges & Tablets and Others
Independently Analyzed by Annual Sales in US$ Million for
the Years 2000 through 2010 (includes corresponding
Graph/Chart) III-25

Table 33: UK Long Term Projections for Smoking Cessation
Aids by Product Segment - Nicotine Gum, Nicotine Patches,
Lozenges & Tablets, and Others Independently Analyzed by
Annual Sales in US$ Million for the Years 2011 through 2015
(includes corresponding Graph/Chart) III-26

Table 34: UK 10-Year Perspective for Smoking Cessation Aids
by Product Segment - Percentage Breakdown of Dollar Sales
for Nicotine Gum, Nicotine Patches, Lozenges & Tablets and
Others for the Years 2003,2008 and 2012 (includes
corresponding Graph/Chart) III-26

3d. Italy III-27
A.Market Analysis III-27
Outlook III-27
B.Market Analytics III-27
Table 35: Italian Recent Past, Current & Future Analysis for
Smoking Cessation Aids by Product Segment - Nicotine Gum,
Nicotine Patches, Lozenges and Tablets and Others
Independently Analyzed by Annual Sales in US$ Million for
the Years 2000 through 2010 (includes corresponding
Graph/Chart) III-27

Table 36: Italian Long Term Projections for Smoking
Cessation Aids by Product Segment - Nicotine Gum, Nicotine
Patches, Lozenges & Tablets, and Others Independently
Analyzed by Annual Sales in US$ Million for the Years 2011
through 2015 (includes corresponding Graph/Chart) III-28

Table 37: Italian 10-Year Perspective for Smoking Cessation
Aids by Product Segment - Percentage Breakdown of Dollar
Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets
and Others for the Years 2003, 2008 and 2012 (includes
corresponding Graph/Chart) III-28

3e. Spain III-29
A.Market Analysis III-29
Outlook III-29
B.Market Analytics III-29
Table 38: Spanish Recent Past, Current & Future Analysis
for Smoking Cessation Aids by Product Segment - Nicotine
Gum, Nicotine Patches, Lozenges & Tablets and Others
Independently Analyzed by Annual Sales in US$ Million for
the Years 2000 through 2010 (includes corresponding
Graph/Chart) III-29

Table 39: Spanish Long Term Projections for Smoking
Cessation Aids by Product Segment - Nicotine Gum, Nicotine
Patches, Lozenges & Tablets, and Others Independently
Analyzed by Annual Sales in US$ Million for the Years 2011
through 2015 (includes corresponding Graph/Chart) III-30

Table 40: Spanish 10-Year Perspective for Smoking Cessation
Aids by Product Segment - Percentage Breakdown of Dollar
Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets
and Others for the Years 2003, 2008 and 2012 (includes
corresponding Graph/Chart) III-30

3f. Rest of Europe III-31
A.Market Analysis III-31
Outlook III-31
B.Market Analytics III-31
Table 41: Rest of Europe Recent Past, Current & Future
Analysis for Smoking Cessation Aids by Product Segment -
Nicotine Gum, Nicotine Patches, Lozenges & Tablets and
Others Independently Analyzed by Annual Sales in US$ Million
for the Years 2000 through 2010 (includes corresponding
Graph/Chart) III-31

Table 42: Rest of Europe Long Term Projections for Smoking
Cessation Aids by Product Segment - Nicotine Gum, Nicotine
Patches, Lozenges & Tablets, and Others Independently
Analyzed by Annual Sales in US$ Million for the Years 2011
through 2015 (includes corresponding Graph/Chart) III-32

Table 43: Rest of Europe 10-Year Perspective for Smoking
Cessation Aids by Product Segment - Percentage Breakdown of
Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges &
Tablets and Others for the Years 2003, 2008 and 2012
(includes corresponding Graph/Chart) III-32

4. Rest of World III-33
A.Market Analysis III-33
Outlook III-33
Smoking Statistics in China III-33
Barriers to Promote Smoking Cessation in the Developing World III-33
Economic Factors III-33
Inadequate Policies to Support Cessation III-33
Low Perception of Risk among Public and Policy Makers III-34
Poor Healthcare Systems and Infrastructure III-34
Lack of Technology III-34
Strategic Corporate Developments III-34
Product Launches III-35
B.Market Analytics III-36
Table 44: Rest of World Recent Past, Current & Future
Analysis for Smoking Cessation Aids - Annual Sales in US$
Million for the Years 2000 through 2010 (includes
corresponding Graph/Chart) III-36

Table 45: Rest of World Long Term Projections for Smoking
Cessation Aids - Annual Sales in US$ Million for the Years
2011 through 2015 (includes corresponding Graph/Chart) III-36

IV. COMPETITIVE LANDSCAPE

RELATED REPORTS

How Britain Shops 2008: Personal Care - Verdict Research: Based on a representative survey of 6,000 adults, this report provides a detailed analysis of consumer trends, customer loyalty and shopper profiles for key players in the personal care market

$ 4 800
May 2008
149 pages

IntroductionVerdict Research: How Britain Shops 2008: Personal Care provides a detailed overview of customers' shopping habits. The report looks at the socio-economic and demographic profile of personal care shoppers, where they shop and whether they are satisfied with their main store for personal ...

Industries : Personal Care

Lush case study: operating as a successful, independent ethical retailer - This case study focuses on the UK natural personal care retailer Lush, a company that has managed to retain its independence. The company's stores stand out from its competitors by

$ 295
June 2008
11 pages

IntroductionThis report on Lush forms part of Datamonitor's case studies series, which explores business practices across a variety of disciplines and business sectors. It looks at how the personal care retailer has managed to retain its independence while other similar outfits are being taken over ...

Industries : Personal Care

Gillette Fusion case study: developing a US$1 billion brand - In April 2008, Procter & Gamble's Gillette Fusion was in line to deliver more than US$1 billion in annual sales, making it the fastest P&G brand to reach the billion mark. This case study looks

$ 295
June 2008
11 pages

IntroductionThis report on Gillette Fusion forms part of Datamonitor's case studies series, which explores business practices across a variety of disciplines and business sectors. It looks at the development and marketing of the razor, to find what has enabled it to grow so strongly in a short space ...

Industries : Personal Care

MarketWatch: Personal Care - June 2008 - This month's Personal Care MarketWatch looks at the buoyant market for natural sleep aids, exemplified by the launch of time release liquid sleep capsules and an effervescent sleep formulation. These have the poten

$ 200
June 2008
26 pages

IntroductionThe Personal Care MarketWatch contains the latest news, analysis and opinion, covering all the month's major issues including mergers and acquisitions, marketing and regulatory issues. It covers the period from April 15 May 14 2008.ScopeGeographic coverage: global Category coverage: pers ...

Industries : Personal Care

Hair and Nail Salons in the US - Industry Market Research Report

$ 835
November 2008

Industry Market Research SynopsisThis Industry Market Research report from IBISWorld provides a detailed analysis of the Hair & Nail Salons in the US industry, including key growth trends, statistics, forecasts, the competitive environment including market shares and the key issues facing the in ...

Industries : Personal Care

World Foot Care Products Market

$ 3 950
April 2008
441 pages

This report analyzes the worldwide markets for Foot Care Products in Millions of US$. The major product segments analyzed are Foot Care Devices, and Foot Care Medications. The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific, and Rest of World. Annual forecasts are p ...

Industries : Personal Care

World Disinfectants Market

$ 3 450
April 2008
861 pages

This report analyzes the worldwide markets for Disinfectants in Millions of US$. The specific product segments analyzed are Aerosols, and Non- Aerosols. The specific end-use segments analyzed are Industrial Processing, Pharma & Health Care, and Consumer & Other Applications. The report provides sepa ...

Industries : Personal Care

Kao Corporation - SWOT Analysis

$ 125
July 2008
26 pages

Table of Contents:This product typically includes the following sections:Key Facts Company Overview Business Description Company History Key Employees Key Employee Biographies Company View SWOT analysis Products & Services Listing Products & Services Analysis ...

Industries : Personal Care

Estee Lauder Companies Inc., The - SWOT Analysis

$ 125
July 2008
32 pages

Industries : Personal Care

Shiseido Company, Limited - SWOT Analysis

$ 125
July 2008
22 pages

Industries : Personal Care

World Smoking Cessation Aids Market - get our PDF brochure

24/7 Customer Service

Contact Shadi now !

(718) 473 08 72
Ask Shadi by email

Related industries

Personal Care Industry

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.